ANGELIQUE PICKETT: Open Payments
NPI 1497044184 · CEDARTOWN, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$640 in 27 payments from 8 companies in 2025. Trend: 2023 $410 · 2024 $449 · 2025 $640
Food & beverage: $640
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 10 | $251 |
| Ionis Pharmaceuticals, Inc. | 3 | $71 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $71 |
| Novartis Pharmaceuticals Corporation | 2 | $66 |
| ARS Pharmaceuticals Operations, Inc. | 2 | $53 |
| Organon LLC | 4 | $48 |
| AstraZeneca Pharmaceuticals LP | 2 | $47 |
| GlaxoSmithKline, LLC. | 2 | $34 |
Products named: DUPIXENT, DAWNZERA, TAKHZYRO, NEFFY, NUCALA, TEZSPIRE, AIRSUPRA, VTAMA.
Industry payments across GA — which companies pay providers there.
